Anthropic Acquires Coefficient Bio For $400M
Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded eight months ago, in an all-stock deal worth just over $400 million on April 3, 2026. The deal brings fewer than ten former Genentech computational biology researchers into Anthropic’s health care life sciences group to accelerate Claude’s application in drug discovery. The acquisition signals intensified competition to embed foundation models in biopharma R&D workflows.
Key Points
- 1Acquires a stealth biotech team of fewer than ten people for just over $400 million.
- 2Signals Anthropic's strategic bet that foundation models can accelerate drug discovery and capture biopharma workflows.
- 3Implies demand for domain expertise to build specialized, enterprise-grade life-sciences AI products and platforms.
Scoring Rationale
Significant acquisition with high novelty and industry-wide scope, showing major model builders doubling down on life sciences. Scored down slightly for limited technical detail about Coefficient Bio's platform and uncertain commercial payoff, but timeliness and strategic implications raise the overall impact.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
